3 on January 21, the National Pharmaceutical Engineering held a seminar on the mid-term revision of the 14th Five-Year Plan in Wuhan. More than 50 members of the company's leadership team, the main persons in charge of various departments of the headquarters, the management of various business units and industry consulting experts attended the meeting. The meeting was presided over by the company's chairman Zhang Qi.

The report of the 20th National Congress of the Communist Party of China has put forward new requirements and made new arrangements for deepening the reform of state-owned assets and state-owned enterprises, enhancing the core competitiveness of enterprises, and accelerating the construction of world-class enterprises. In the post-epidemic era, with the changes in the external environment and the inherent requirements of the company's high-quality development, we are required to stand at a new historical starting point, face more complex environmental conditions, and systematically think, plan, and lay out the reform and development of future enterprises. Among them, the "14th Five-Year Plan" development strategy plays an important role in gatekeeping, planning layout, and system deployment. With the theme of "learning and implementing the top 20 value creation and striving for first-class", this planning seminar focused on the current problems and shortcomings, focusing on the improvement of the core competitiveness of enterprises, high-quality development and other key content exchanges and discussions.

At the meeting, the consulting experts made a report entitled "purifying and shaping adaptability in reconstruction" from the perspective of strategic planning, focusing on the development trend of the industry, the evolution of the external environment, and the thinking of enterprise innovation. Combined with the actual development of the company, this paper puts forward specific suggestions from the aspects of new business development, regional market, brand linkage, project management, operation and management, mechanism construction, human resources, Party building and so on.

General Manager Xu Jihui pointed out in his speech that the company's current achievements are an affirmation of everyone's efforts. The next step is to focus on the company's development strategy positioning, give full play to the two advantages of pharmaceutical engineering consulting and design and the whole industry chain engineering and technical services, focus on the key core content of industry chain collaboration, scientific research innovation, digital transformation development, extension development, and actively help the company's overall strategic goal landing and high-quality development.

Chairman Zhang Qi stressed that one is to improve the political position and attach great importance to it. Combine the implementation of the Party's 20th National Congress of the Communist Party of China and the benchmarking of world-class value creation actions with the mid-term revision of the company's "14th Five-Year Plan" development plan, and implement the planning requirements of the reform of state-owned assets and state-owned enterprises; the second is to take the general project as the core, Continuously provide the whole process of technical services for the medical and health industry, which is the main direction of the current and future development of the Chinese medicine project; the third is to strengthen capacity building, it is necessary to build the core competitiveness ability that can meet the requirements of customers and create value for customers; fourth, all business units should closely focus on the overall strategic goal of Sinophobe Engineering, give full play to the advantages of the whole industrial chain nodes and regional companies, and constantly improve the overall competitiveness of Sinophobe Engineering; fifth, it is necessary to strengthen the construction of talent team, mechanism and party building enterprise culture, Further stimulate the vitality of enterprise development, and strengthen the company's confidence.

(Market and Operations Management Department)